We are live on
!
Find out more
SRIM
Saratoga Research & Investment Management Portfolio holdings
AUM
$1.83B
1-Year Est. Return
18.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.92%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.89B
AUM Growth
-$88.4M
(-4.5%)
Cap. Flow
-$42.7M
Cap. Flow
% of AUM
-2.25%
Top 10 Holdings %
Top 10 Hldgs %
59.31%
Holding
45
New
1
Increased
10
Reduced
27
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$62.2M |
| 2 |
ASML
ASML
|
+$14.9M |
| 3 |
NVIDIA
NVDA
|
+$12.2M |
| 4 |
Honeywell
HON
|
+$9.87M |
| 5 |
Colgate-Palmolive
CL
|
+$6.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$63.6M |
| 2 |
Apple
AAPL
|
+$17.8M |
| 3 |
Becton Dickinson
BDX
|
+$17.4M |
| 4 |
Oracle
ORCL
|
+$12.4M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$7.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.74% |
| 2 | Healthcare | 16.73% |
| 3 | Consumer Staples | 14.66% |
| 4 | Communication Services | 13.96% |
| 5 | Financials | 10.92% |
Similar funds
SI
DWT
OQS
RP
HMC
ABTD
FCIM
CPSAC
Saratoga Research & Investment Management's Q1 2025 Portfolio in Review
As of Q1 2025, Saratoga Research & Investment Management held 45 positions worth $1.89B, down 4.5% from $1.98B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 4.4%. Saratoga Research & Investment Management opened 1 new position and exited 1, leaving the 45-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Staples.
- Saratoga Research & Investment Management's largest Q1 2025 buy was NVIDIA: 96,265 shares worth $10.4M.
- Saratoga Research & Investment Management added most to Novo Nordisk in Q1 2025, an estimated $62.2M increase.
- Saratoga Research & Investment Management's biggest Q1 2025 reduction was RTX Corp, cutting an estimated $63.6M.
- Saratoga Research & Investment Management fully exited Biogen in Q1 2025, selling an estimated $221K.
- Saratoga Research & Investment Management's ten largest holdings make up 59% of its $1.89B portfolio in Q1 2025.
- Saratoga Research & Investment Management opened 1 new position and closed 1 in Q1 2025.
- Saratoga Research & Investment Management's portfolio value fell 4.5% quarter-over-quarter to $1.89B.
Based on Saratoga Research & Investment Management's 13F filing for Q1 2025, filed 12 May 2025.